J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
Contents: July 2001, Volume 41, Supplement 1   [Index by Author] 
       Editorials
       Articles


 
Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Editorials:

WC Eckelman, R Waterhouse, and R Frank
Nuclear imaging and biomarkers in drug development using approved radiopharmaceuticals
J Clin Pharmacol 2001 41: S4 -S6. [PDF]  

Articles:

D Burns
The 2000 Alfred P. Wolf Award
J Clin Pharmacol 2001 41: S7 -S8. [PDF]  

JS Fowler and ND Volkow
18FDG for the study of central nervous system drugs
J Clin Pharmacol 2001 41: S9 -S10. [PDF]  

P Herscovitch
Can [15O]water be used to evaluate drugs?
J Clin Pharmacol 2001 41: S11 -S20. [Abstract] [PDF]  

I Tracey
Prospects for human pharmacological functional magnetic resonance imaging (phMRI)
J Clin Pharmacol 2001 41: S21 -S28. [PDF]  

CA Slapak, J Dahlheimer, and D Piwnica-Worms
Reversal of multidrug resistance with LY335979: functional analysis of P-glycoprotein-mediated transport activity and its modulation in vivo
J Clin Pharmacol 2001 41: S29 -S38. [PDF]  

Ballinger, JR
99mTc-tetrofosmin for functional imaging of P-glycoprotein modulation in vivo
J Clin Pharmacol 2001 41: S39 -S47. [Abstract] [PDF]  

NH Hendrikse, J Bart, EG de Vries, HJ Groen, WT van der Graaf, and W Vaalburg
P-glycoprotein at the blood-brain barrier and analysis of drug transport with positron-emission tomography
J Clin Pharmacol 2001 41: S48 -S54. [PDF]  

HI Kornblum and SR Cherry
The use of microPET for the development of neural repair therapeutics: studies in epilepsy and lesion models
J Clin Pharmacol 2001 41: S55 -S63. [PDF]  

S Kapur
Neuroimaging and drug development: an algorithm for decision making
J Clin Pharmacol 2001 41: S64 -S71. [PDF]  

DJ Doudet
Monitoring disease progression in Parkinson's disease
J Clin Pharmacol 2001 41: S72 -S80. [PDF]  

SL Meijer, A Dols, HM Hu, S Jensen, CH Poehlein, Y Chu, H Winter, J Yamada, T Moudgil, WJ Wood, T Doran, L Justice, B Fisher, P Wisner, J Wood, JT Vetto, R Mehrotra, S Rosenheim, AD Weinberg, R Bright, E Walker, R Puri, Smith JW, 2nd, WJ Urba, and BA Fox
Immunological and molecular analysis of the sentinel lymph node: a potential approach to predict outcome, tailor therapy, and optimize parameters for tumor vaccine development
J Clin Pharmacol 2001 41: S81 -S94. [PDF]  

C Halldin
Serotonin 5-HT1A receptor imaging in the human brain with positron-emission tomography: coordination and the standardization and dissemination of methodology
J Clin Pharmacol 2001 41: S95 . [PDF]  

KA Krohn, DA Mankoff, and JF Eary
Imaging cellular proliferation as a measure of response to therapy
J Clin Pharmacol 2001 41: S96 -S103. [Abstract] [PDF]  

AA Lammertsma
Measurement of tumor response using [18F]-2-fluoro-2-deoxy-D-glucose and positron-emission tomography
J Clin Pharmacol 2001 41: S104 -S106. [PDF]  

R Innis, S Ferguson, L Brady, R Esmond, and R Frank
Positron-emission tomography tracers as intellectual property
J Clin Pharmacol 2001 41: S107 . [PDF]  

R Innis
The molecular imaging branch of NIMH: PET and SPECT tracers
J Clin Pharmacol 2001 41: S108 -S109. [PDF]  

SM Ferguson
Licensing and distribution of research tools: National Institutes of Health perspective
J Clin Pharmacol 2001 41: S110 -S112. [PDF]  

RW Esmond
The patenting of tools for drug discovery and development
J Clin Pharmacol 2001 41: S112 -S115. [PDF]  

L Brady
Neuroimaging consortium workshop: development of novel PET and SPECT ligands for brain imaging
J Clin Pharmacol 2001 41: S116 -S117. [Abstract] [PDF]  

R Katz, HN Wagner, M Fauntleroy, T Kuwert, and R Frank
The use of imaging as biomarkers in drug development: regulatory issues worldwide
J Clin Pharmacol 2001 41: S118 . [PDF]  

M Fauntleroy
Submission of images to the center for biologics evaluation and research in support of license applications for therapeutic agents
J Clin Pharmacol 2001 41: S119 -S121. [Abstract] [PDF]  

T Kuwert
Regulation of the production and use of radiopharmaceuticals in Germany and Europe
J Clin Pharmacol 2001 41: S121 -S122. [PDF]  

R Katz
Regulatory aspects of nuclear imaging in neuropharmacology
J Clin Pharmacol 2001 41: S122 -S124. [PDF]  

Wagner HN, Jr
Nonimaging detectors in drug development and approval
J Clin Pharmacol 2001 41: S125 -S126. [Abstract] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American College of Clinical Pharmacology